Adjunct Hypertonic Saline in Patients with Diffuse Edema Due to Heart Failure: A Randomized Double-Blinded Clinical Trial.

Chronic heart failure Diuretic resistant Furosemide Generalized edema Hypertonic saline solution

Journal

Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407

Informations de publication

Date de publication:
2021
Historique:
entrez: 14 12 2021
pubmed: 15 12 2021
medline: 15 12 2021
Statut: ppublish

Résumé

In patients with diuretic resistance due to heart failure, higher doses or continuous furosemide infusion and adding hypertonic saline solution (HSS) to diuretics could be effective. The goal of this study was to assess the effectiveness of hypertonic saline solution administration in weight loss of hospitalized patients with diuretic-resistant edema due to heart failure. In a randomized double-blinded clinical trial, adult patients with diffuse peripheral edema due to heart failure who were unresponsive to 80 mg of oral furosemide were enrolled. The patients were randomized into two groups. In the intervention and control groups, patients received 150 mL of HSS and normal saline, respectively. Subjects in both groups received 250 mg IV furosemide every 12 h for 48 h. The change in body weight, urine output, blood pressure, uric acid, urine osmolality, blood biochemistry, and urinary cystatin C levels were assessed. Based on defined inclusion and exclusion criteria, 28 patients, 14 in each group, were recruited. The groups were similar in demographic and baseline laboratory characteristics. A significant decrease in body weight was observed in the intervention group (

Identifiants

pubmed: 34903983
doi: 10.22037/ijpr.2020.113853.14526
pmc: PMC8653679
doi:

Types de publication

Journal Article

Langues

eng

Pagination

216-222

Références

Ann Pharmacother. 2003 May;37(5):695-700
pubmed: 12708949
Int Urol Nephrol. 2014 Sep;46(9):1809-13
pubmed: 24824145
J Palliat Med. 2016 Jul;19(7):771-7
pubmed: 27078226
Am J Med Sci. 2011 Jul;342(1):27-37
pubmed: 21701268
Am J Cardiol. 1988 Sep 9;62(8):72E-75E
pubmed: 3414540
Eur J Heart Fail. 2008 Apr;10(4):396-403
pubmed: 18353715
Am J Med. 1999 Jan;106(1):90-6
pubmed: 10320123
Kidney Int. 1988 Sep;34(3):361-7
pubmed: 3172644
Sao Paulo Med J. 1995 Nov-Dec;113(6):1053-60
pubmed: 8731291
J Pain Symptom Manage. 2018 Apr;55(4):1179-1183
pubmed: 29288880
J Pain Symptom Manage. 2009 Mar;37(3):419-23
pubmed: 18790601
JACC Heart Fail. 2020 Mar;8(3):199-208
pubmed: 32035891
Adv Ther. 2015 Oct;32(10):971-82
pubmed: 26521190
Intensive Care Med. 2020 Sep;46(9):1683-1695
pubmed: 32519005
Anesth Analg. 1989 Dec;69(6):714-20
pubmed: 2480072
Nutr Metab Cardiovasc Dis. 2011 May;21(5):372-9
pubmed: 20346637
Am Heart J. 2003 Mar;145(3):459-66
pubmed: 12660669
Int J Cardiol. 2013 Jul 15;167(1):34-40
pubmed: 22243938
Electrolyte Blood Press. 2015 Jun;13(1):17-21
pubmed: 26240596
Int J Nephrol. 2015;2015:975934
pubmed: 26294976

Auteurs

Mohammad Parsa Mahjoob (MP)

Cardiovascular Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Farnaz Barzi (F)

Imam Hussein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Amirahmad Nassiri (A)

Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Alireza Kaveh (A)

Shahid Moddares Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mahshid Haghi (M)

Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.

Mahshad Ghoddusi (M)

Emam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Sistanizad (M)

Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH